Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-09

Clinical Trial Update: Apathy Cure Through Bupropion in Huntington's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether bupropion can improve apathy in Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Apathy, Huntington's Disease | Phase 2 | Status: COMPLETED